chr8-144318093-A-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_012079.6(DGAT1):c.751+2T>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,527,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_012079.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DGAT1 | NM_012079.6 | c.751+2T>C | splice_donor_variant, intron_variant | ENST00000528718.6 | NP_036211.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DGAT1 | ENST00000528718.6 | c.751+2T>C | splice_donor_variant, intron_variant | 1 | NM_012079.6 | ENSP00000482264.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000130 AC: 24AN: 184594Hom.: 0 AF XY: 0.000123 AC XY: 12AN XY: 97422
GnomAD4 exome AF: 0.000103 AC: 142AN: 1375652Hom.: 0 Cov.: 33 AF XY: 0.000101 AC XY: 68AN XY: 674938
GnomAD4 genome AF: 0.000131 AC: 20AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74354
ClinVar
Submissions by phenotype
Congenital diarrhea 7 with exudative enteropathy Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 20, 2022 | The c.751+2T>C variant in DGAT1 has been reported in 6 individuals with congenital diarrheal disorders (CDD), all of whom carried the variant in the homozygous or compound heterozygous state, and segregated with disease in 3 affected siblings from 3 families (Haas 2012 PMID: 23114594, Yourshaw 2014, Niu 2015, Stephen 2016 PMID: 26883093, Schlegel 2018 PMID: 30095213, Ziats 2020 PMID: 31618753). It was also identified in 0.48% (19/3924) of Ashkenazi Jewish chromosomes by the gnomAD (http://gnomad.broadinstitute.org); however, this frequency is consistent with the fact that it is likely to be a founder variant in the Ashkenazi Jewish population. This variant has also been reported in ClinVar (Variation ID 139512). The c.751+2T>C variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and has been demonstrated to cause altered splicing leading to an abnormal or absent protein (Haas 2012 PMID: 23114594, ). In vitro functional studies provide some evidence that the altered splicing may impact protein stability (Haas 2012 PMID: 23114594, Schlegel 2018 PMID: 30095213). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive CDD. ACMG/AMP criteria applied: PVS1_Strong, PM3_Strong, PP1_Strong, PS3_Moderate. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | This mutation has been previously reported as disease-causing and was found in two affected individuals in our laboratory, including a homozygote and a compound hetrozygote. Both inidividuals had FTT, diarrhea, significant fat malabsorption. Heterozygotes are expected to be asymptomatic carriers. - |
Pathogenic, criteria provided, single submitter | clinical testing | Elsea Laboratory, Baylor College of Medicine | Apr 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | research | Aleixo Muise Laboratory, Hospital For Sick Children | Jul 05, 2024 | PVS1;PM2;PM3;PP3;PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 03, 2012 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | This sequence change affects a donor splice site in intron 8 of the DGAT1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs148665132, gnomAD 0.5%). Disruption of this splice site has been observed in individual(s) with congenital chronic diarrhea (PMID: 23114594, 26883093). It has also been observed to segregate with disease in related individuals. This variant is also known as g.13827T>C and g.145541756A>G. ClinVar contains an entry for this variant (Variation ID: 139512). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that disruption of this splice site affects DGAT1 function (PMID: 23114594). Studies have shown that disruption of this splice site results in skipping of exon 8, but is expected to preserve the integrity of the reading-frame (PMID: 23114594). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2024 | Published functional studies demonstrate a damaging effect; specifically, cDNA analysis revealed exon 8 skipping leading to the deletion of 25 amino-acids from the MBOAT domain, and molecular analysis of the mutant allele indicated a total loss of function, with no detectable DGAT1 protein or activity produced (PMID: 23114594); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26883093, 23114594, 30095213, 31618753, 31589614) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2018 | - - |
DGAT1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 20, 2024 | The DGAT1 c.751+2T>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. In the literature, this variant is also reported as 145541756 A>G, g.13827T>C, or rs148665132. This variant has been reported in the homozygous state in multiple individuals with congenital chronic diarrhea (Haas et al. 2012. PubMed ID: 23114594; Family 2, Stephen et al. 2016. PubMed ID: 26883093; Schlegel et al. 2018. PubMed ID: 30095213). This variant has also been shown to segregate with disease in the above reported families. Functional analyses have shown that this variant causes skipping of exon 8 and abolishes DGAT1 protein activity (Reported as 145541756 A>G, Haas et al. 2012. PubMed ID: 23114594). This variant is reported in 0.48% of alleles in individuals of Ashkenazi Jewish descent in gnomAD and is reported as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/139512/). Variants that disrupt the consensus splice donor site in DGAT1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at